MFDS — authorised 8 May 2020
- Marketing authorisation holder: LOXO ONCOLOGY INC
- Status: likely_approved
🇰🇷 Retevmo in South Korea
MFDS authorised Retevmo on 8 May 2020
Marketing authorisation
Retevmo in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in South Korea
Frequently asked questions
Is Retevmo approved in South Korea?
Yes. MFDS authorised it on 8 May 2020.
Who is the marketing authorisation holder for Retevmo in South Korea?
LOXO ONCOLOGY INC holds the South Korean marketing authorisation.